LALPATHLAB stock news
This page provides real-time market news, earnings updates, and company announcements related to Dr. Lal PathLabs Limited (LALPATHLAB).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 20:09 IST
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer
Finviz2026-04-13 11:03:45
ASP Isotopes Inc. Provides Business Update
Finviz2026-04-13 11:33:07
3D Systems Accelerates Production-Scale Additive Manufacturing with New High-Throughput Platform and Next-Generation Factory Software
Finviz2026-04-13 11:33:06
Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors
Finviz2026-04-13 11:33:07
3 E Network Vice President Introduces First Strategic Blueprint for Semiconductor and Compute Infrastructure Development
Finviz2026-04-13 11:54:08
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
Finviz2026-04-13 13:03:11
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition
Finviz2026-04-13 13:21:41
Disrupting Surveillance: RF-Powered AI Video Intelligence Sets New Industry Standard
Finviz2026-04-13 14:06:11
Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units
Finviz2026-04-13 16:54:08
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
Finviz2026-04-13 20:42:42
Keurig Dr Pepper Announces Results of Post-Closing Acceptance Period for Offer for JDE Peet's
Finviz2026-04-13 21:03:50
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway
Finviz2026-04-14 11:00:53
Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research
Finviz2026-04-14 11:03:55
AVITA Medical Announces Positive Interim Results from Cohealyx Study Demonstrating Accelerated Time to Skin Grafting
Finviz2026-04-14 11:48:07
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
Finviz2026-04-14 12:06:47
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
Finviz2026-04-14 12:06:47
TOMI Reports Strong Q1 2026 Sales of High-Margin BIT Solution, Indicating Positive Growth Trends
Finviz2026-04-14 12:33:57
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx's TAMP Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
Finviz2026-04-14 12:36:41
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
NYSE Content Update: OpenLoop Health Debuts At-Home Sleep Apnea Test with 98% Accuracy
Finviz2026-04-14 12:57:48
Virtuix Delivers Omni One to Florida Gulf Coast University for Use in Physical Therapy and Clinical Simulation
Finviz2026-04-14 13:18:42
Tuesday Health Expands National Footprint With Humana Partnership to Advance Value-Based Palliative Care
Finviz2026-04-14 13:21:46
Duke Energy invests $600,000 to train North Carolina's future energy workforce
Finviz2026-04-14 14:51:44
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
Finviz2026-04-14 20:06:56
3 E Network Vice President Introduces First Strategic Blueprint for Semiconductor and Compute Infrastructure Development
Finviz2026-04-13 11:54:08
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
Finviz2026-04-13 13:03:11
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition
Finviz2026-04-13 13:21:41
Disrupting Surveillance: RF-Powered AI Video Intelligence Sets New Industry Standard
Finviz2026-04-13 14:06:11
Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units
Finviz2026-04-13 16:54:08
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
Finviz2026-04-13 20:42:42
Keurig Dr Pepper Announces Results of Post-Closing Acceptance Period for Offer for JDE Peet's
Finviz2026-04-13 21:03:50
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway
Finviz2026-04-14 11:00:53
Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research
Finviz2026-04-14 11:03:55
AVITA Medical Announces Positive Interim Results from Cohealyx Study Demonstrating Accelerated Time to Skin Grafting
Finviz2026-04-14 11:48:07
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
Finviz2026-04-14 12:06:47
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
Finviz2026-04-14 12:06:47
TOMI Reports Strong Q1 2026 Sales of High-Margin BIT Solution, Indicating Positive Growth Trends
Finviz2026-04-14 12:33:57
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx's TAMP Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
Finviz2026-04-14 12:36:41
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
NYSE Content Update: OpenLoop Health Debuts At-Home Sleep Apnea Test with 98% Accuracy
Finviz2026-04-14 12:57:48
Virtuix Delivers Omni One to Florida Gulf Coast University for Use in Physical Therapy and Clinical Simulation
Finviz2026-04-14 13:18:42
Tuesday Health Expands National Footprint With Humana Partnership to Advance Value-Based Palliative Care
Finviz2026-04-14 13:21:46
Duke Energy invests $600,000 to train North Carolina's future energy workforce
Finviz2026-04-14 14:51:44
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
Finviz2026-04-14 20:06:56
LALPATHLAB stock price change
On the last trading day, LALPATHLAB stock closed at 1379.80 INR, with a price change of -1.77% for the day.
Trade stock perpsLALPATHLAB stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more